DWA
ISEE

Dorsey Wright & Associates’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Dorsey Wright & Associates’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,559
Closed -$5K – 377
2020
Q1 		$5K Buy
+1,559
New +$9.11K ﹤0.01% 256

Other funds holding ISEE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dorsey Wright & Associates's ISEE Position: Q2 2020 in Review

Dorsey Wright & Associates sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2020, closing a stake of 1,559 shares — an estimated $5K sold.

Dorsey Wright & Associates first reported a position in ISEE in Q1 2020 and held it in 1 quarter. The position peaked at $5K in Q1 2020. 119 funds tracked by Wall St. Rank hold ISEE as of Q2 2020.

  • Dorsey Wright & Associates reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,559 IVERIC bio, Inc. Common Stock shares in Q2 2020, an estimated $5K.
  • Dorsey Wright & Associates first reported a position in IVERIC bio, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's IVERIC bio, Inc. Common Stock position peaked at $5K in Q1 2020.
  • 119 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2020.

Based on Dorsey Wright & Associates's 13F filing for Q2 2020, filed 23 Jul 2020.